Comparison of actionable alterations in cancers with kinase fusion, mutation, and copy number alteration.
Suzuki S, Akahane T, Tanimoto A, Higashi M, Kitazono I, Kirishima M, Nishigaki M, Ikeda T, Kanemitsu S, Nakazawa J, Akahane E, Nishihara H, Uozumi K, Yoshimitsu M, Ishitsuka K, Ueno SI.
Suzuki S, et al.
PLoS One. 2025 Jan 23;20(1):e0305025. doi: 10.1371/journal.pone.0305025. eCollection 2025.
PLoS One. 2025.
PMID: 39847581
Free PMC article.